Arvind Sanger Cautiously Optimistic on India Eyes Earnings Revival Spotify Surges 13 on AI Music Partnership with Universal Music Group and Upbeat Guidance Consumer Sentiment Hits Record Low in May as Rising Gas Prices from Iran Conflict Weigh on Outlook Paul Tudor Jones Sees No Chance Kevin Warsh Could Persuade Fed to Cut Rates Custard Apple Gains Traction in Niche Fruit Markets Despite Export Hurdles Retail Investors Gain Unprecedented Access to SpaceX IPO via Major Brokerage Platforms Eagle Point Credit Company Inc ECC Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines SBDS Q1 2026 Earnings Significant Loss Reported Amidst Operational Challenges Worthington Steel Inc WS Q1 2026 Earnings EPS Misses Estimates Stock Still Rises VRNS Q1 2026 Earnings Earnings Surprise Overshadows Missing Revenue Detail RDWR Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction VLYPO Q1 2026 Earnings Preferred Series B Reports Strong EPS Beat as Valley National Bancorp Outperforms Estimates Brookfield Property Partners LP Preferred Stock BPYPN Holds Steady Near 14 Up 022 Alpha Metallurgical Resources Gains 178 as Coal Markets Show Resilience Veris Residential VRE Hovers Near Support With Minimal Movement Anika Therapeutics ANIK Slides 16 Amidst Market Pressure Key Levels to Watch Broadstone Net Lease BNL Slips Slightly as Resistance Holds Firm SpaceX OpenAI Valuations Could Surpass Berkshire Hathaway on Debut Trading Day Polymarket Traders Suggest UDR Q1 2026 Earnings Massive EPS Beat of 413 Surprises Analysts Dogwood Therapeutics Inches Lower as Stock Tests Key Support Near 169 Roper Technologies ROP Holds Steady at 31663 as Market Awaits Direction Alcon Inc ALC Holds Steady Near Key Support as Traders Await Catalyst SkyWest Inc SKYW Climbs 185 as Regional Aviation Demand Remains Robust DAQO New Energy Slides as Solar Polysilicon Headwinds Persist Barings Participation Investors MPV Gains 146 Testing Key Resistance at 1805 Sarepta Therapeutics SRPT Edges Higher Amid Modest Gains MoonLake Immunotherapeutics MLTX Holds Near Support as Biotech Sector Sends Mixed Signals